All products are all natural, fragrance-free, gluten-free, and cruelty-free
This is the most consistently reported side effect and tends to persist
Table of Contents Origins of the Pancreatic Safety Concern What Long-Term Data Reveal Absolute vs Relative Risk in Context Practical Guidance for Patient Counseling Origins of the Pancreatic Safety Concern Early safety signals suggesting a pancreatic cancer risk with GLP-1 receptor agonists emerged shortly after these drugs were introduced for type 2 diabetes
Early research suggests this effect accounts for 2-4% of additional weight loss beyond what dual agonism achieves, a number that compounds significantly over a 48 to 68 week treatment period
But it takes thoughtful consideration of how or if you will offer coverage, what tools youll have in place to help ensure your drug spend aligns with your coverage strategy, and effective ways you can empower your members to learn and put in practice the necessary lifestyle changes that are critical to achieving and sustaining better outcomes
Eligibility details for Medicare GLP-1 weight loss drugs under the new Bridge program: People with BMIs of 35 or greater